Hologic Inc (HOLX) investors sentiment decreased to 0.74 in 2017 Q4. It’s down -0.14, from 0.88 in 2017Q3. The ratio dropped, as 164 active investment managers opened new and increased positions, while 222 sold and decreased stock positions in Hologic Inc. The active investment managers in our database now own: 264.36 million shares, down from 265.54 million shares in 2017Q3. Also, the number of active investment managers holding Hologic Inc in top ten positions increased from 2 to 3 for an increase of 1. Sold All: 57 Reduced: 165 Increased: 94 New Position: 70.
Analysts expect Deere & Company (NYSE:DE) to report $3.33 EPS on May, 18 before the open.They anticipate $0.84 EPS change or 33.73% from last quarter’s $2.49 EPS. DE’s profit would be $1.08B giving it 11.06 P/E if the $3.33 EPS is correct. After having $1.31 EPS previously, Deere & Company’s analysts see 154.20% EPS growth. The stock increased 1.25% or $1.82 during the last trading session, reaching $147.35. About 1.89 million shares traded. Deere & Company (NYSE:DE) has risen 41.99% since May 17, 2017 and is uptrending. It has outperformed by 30.44% the S&P500.
Investors sentiment increased to 1.03 in Q4 2017. Its up 0.10, from 0.93 in 2017Q3. It increased, as 50 investors sold Deere & Company shares while 338 reduced holdings. 142 funds opened positions while 257 raised stakes. 209.89 million shares or 1.63% less from 213.38 million shares in 2017Q3 were reported. 9,358 were reported by First Savings Bank. Campbell And Invest Adviser Limited Liability Company owns 1,305 shares for 0.15% of their portfolio. Regal Invest Advsr Lc accumulated 1,837 shares. 4,276 were accumulated by Fisher Asset Mngmt Limited. Lincoln Capital Ltd Co owns 3,485 shares. Robeco Institutional Asset Bv has invested 0.34% of its portfolio in Deere & Company (NYSE:DE). Arrowstreet Limited Partnership reported 581,515 shares. Credit Suisse Ag invested in 450,850 shares or 0.06% of the stock. Glenview Retail Bank Trust Dept holds 0.32% of its portfolio in Deere & Company (NYSE:DE) for 4,500 shares. Carret Asset Mngmt Ltd has invested 0.19% in Deere & Company (NYSE:DE). Beese Fulmer Management reported 1,550 shares. Abner Herrman And Brock Lc holds 0.17% of its portfolio in Deere & Company (NYSE:DE) for 6,330 shares. Bender Robert And Associates reported 1,360 shares or 0.12% of all its holdings. 3,410 were reported by Stewart And Patten Company Ltd Liability Company. Oarsman Capital has 0.19% invested in Deere & Company (NYSE:DE) for 2,889 shares.
Since December 11, 2017, it had 0 insider buys, and 9 selling transactions for $66.91 million activity. Jones Mary K.W. sold $1.69 million worth of stock. ALLEN SAMUEL R sold $44.13 million worth of stock or 269,353 shares. Another trade for 22,095 shares valued at $3.76M was sold by Field James M.. On Monday, December 11 May John C II sold $3.15M worth of Deere & Company (NYSE:DE) or 20,835 shares. Another trade for 15,083 shares valued at $2.52 million was made by Gilles Jean H on Friday, February 23. $972,253 worth of stock was sold by Reed Cory J on Monday, December 11. 11,235 shares were sold by Guinn Max A, worth $1.90M on Tuesday, January 16.
Deere & Company, together with its subsidiaries, makes and distributes agriculture and turf, and construction and forestry equipment worldwide. The company has market cap of $47.71 billion. The company??s Agriculture and Turf segment provides agriculture and turf equipment, and related service parts, including large, medium, and utility tractors; tractor loaders; combines, cotton pickers, cotton strippers, and sugarcane harvesters; related harvesting front-end equipment; sugarcane loaders and pull-behind scrapers; and tillage, seeding, and application equipment comprising sprayers, and nutrient management and soil preparation machinery. It has a 33.5 P/E ratio. This segment also offers hay and forage equipment, such as self-propelled forage harvesters and attachments, balers, and mowers; turf and utility equipment, including riding lawn equipment and walk-behind mowers, golf course equipment, utility vehicles, and commercial mowing equipment, as well as associated implements; integrated agricultural management systems technology and solutions; and other outdoor power products.
More news for Deere & Company (NYSE:DE) were recently published by: Benzinga.com, which released: “Upcoming Earnings: Home Improvement Retailer Home Depot Reports Before Tuesday’s Open” on May 14, 2018. Benzinga.com‘s article titled: “Get Out The Shopping Cart: Retail In Focus Ahead Of Key Data, Earnings” and published on May 14, 2018 is yet another important article.
Among 30 analysts covering Deere & Company (NYSE:DE), 16 have Buy rating, 2 Sell and 12 Hold. Therefore 53% are positive. Deere & Company has $231 highest and $63 lowest target. $152.16’s average target is 3.26% above currents $147.35 stock price. Deere & Company had 128 analyst reports since July 27, 2015 according to SRatingsIntel. The firm has “Sell” rating given on Monday, August 24 by UBS. The rating was upgraded by PiperJaffray to “Neutral” on Monday, November 28. The stock of Deere & Company (NYSE:DE) has “Buy” rating given on Thursday, December 1 by Bank of America. BMO Capital Markets maintained the stock with “Outperform” rating in Wednesday, February 21 report. The company was maintained on Tuesday, April 11 by Stifel Nicolaus. The rating was upgraded by HSBC on Tuesday, November 21 to “Buy”. The stock of Deere & Company (NYSE:DE) earned “Buy” rating by Stifel Nicolaus on Wednesday, August 23. The stock of Deere & Company (NYSE:DE) has “Hold” rating given on Friday, February 16 by Jefferies. The stock of Deere & Company (NYSE:DE) earned “Buy” rating by UBS on Tuesday, May 31. The stock of Deere & Company (NYSE:DE) has “Hold” rating given on Thursday, January 18 by Jefferies.
The stock increased 2.16% or $0.82 during the last trading session, reaching $38.7. About 1.82 million shares traded. Hologic, Inc. (HOLX) has declined 11.91% since May 17, 2017 and is downtrending. It has underperformed by 23.46% the S&P500.
Ratings analysis reveals 80% of Hologic’s analysts are positive. Out of 5 Wall Street analysts rating Hologic, 4 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $44.0 while the high is $48.0. The stock’s average target of $46 is 18.86% above today’s ($38.7) share price. HOLX was included in 5 notes of analysts from September 23, 2016. The company was initiated on Wednesday, January 18 by Deutsche Bank. Needham upgraded Hologic, Inc. (NASDAQ:HOLX) rating on Wednesday, February 15. Needham has “Buy” rating and $46.0 target. Barclays Capital upgraded the shares of HOLX in report on Friday, September 23 to “Overweight” rating. Piper Jaffray upgraded the stock to “Overweight” rating in Wednesday, January 4 report. The firm has “Neutral” rating given on Wednesday, February 15 by Bank of America.
More news for Hologic, Inc. (NASDAQ:HOLX) were recently published by: Benzinga.com, which released: “Leerink Downgrades Hologic After ‘Lower Quality’ Q2 Revenue Beat” on May 03, 2018. Seekingalpha.com‘s article titled: “Hologic (HOLX) Q2 2018 Results – Earnings Call Transcript” and published on May 03, 2018 is yet another important article.
Analysts await Hologic, Inc. (NASDAQ:HOLX) to report earnings on August, 1. They expect $0.56 EPS, up 12.00% or $0.06 from last year’s $0.5 per share. HOLX’s profit will be $152.89M for 17.28 P/E if the $0.56 EPS becomes a reality. After $0.53 actual EPS reported by Hologic, Inc. for the previous quarter, Wall Street now forecasts 5.66% EPS growth.
Waterstone Capital Management L.P. holds 13.89% of its portfolio in Hologic, Inc. for 446,800 shares. Domini Impact Investments Llc owns 5,877 shares or 5.14% of their US portfolio. Moreover, Kahn Brothers Group Inc De has 4.64% invested in the company for 691,667 shares. The New York-based American Capital Management Inc has invested 3% in the stock. Endurant Capital Management Lp, a California-based fund reported 222,844 shares.
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company has market cap of $10.57 billion. It operates through four divisions: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It has a 10.24 P/E ratio. The Diagnostics segment provides Aptima family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assays, Procleix family of assays for blood screening, instrumentation, Invader chemistry platform, ThinPrep system, and rapid fetal fibronectin test.
Since January 1, 0001, it had 3 buys, and 2 sales for $195,159 activity.